Sophono is a medical device manufacturer founded in 2009. The company specializes in implantable, bone conduction hearing devices designed for individuals with severe to profound hearing loss or impairment. Their FDA-cleared product, Alpha 1, uses magnets to secure external sound processors, effectively eliminating the problematic abutment of traditional devices. The company focuses on treating those with conductive hearing loss, mixed hearing loss, and single-ear deafness. In April 2014, Sophono received a $500.00K investment in a Venture Round. Despite not having specific headquarters listed, Sophono operates within the Health Care and Manufacturing industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $500.00K | - | 17 Apr 2014 | |
| Venture Round | $1.02M | - | 11 Feb 2014 | |
| Series B | $7.00M | 1 | Wexford Capital | 27 Aug 2012 |
No recent news or press coverage available for Sophono.
We care about your data, and we'd love to use cookies make your experience better.
